Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,518,142 | 2,308,664 | 1,754,095 | 907,174 | 2,566,807 |
| Marketable Securities | 572,285 | 389,300 | 56,612 | 221,033 | 274,404 |
| Receivables | 3,216,014 | 3,076,082 | 3,303,971 | 3,597,620 | 3,387,878 |
| Inventories | 1,898,390 | 1,902,814 | 1,900,665 | 1,862,861 | 2,024,953 |
| Other current assets | 1 | 1 | 0 | 0 | 0 |
| TOTAL | $8,204,832 | $7,676,861 | $7,015,343 | $6,588,688 | $8,254,042 |
| Non-Current Assets | |||||
| PPE Net | 3,801,096 | 3,574,971 | 3,502,262 | 3,557,142 | 4,125,149 |
| Investments And Advances | 319,920 | 310,128 | 329,449 | 279,399 | 152,625 |
| Intangibles | 321,110 | 218,432 | 216,372 | 207,995 | 245,697 |
| Other Non-Current Assets | 1,012,733 | 922,184 | 987,160 | 1,109,257 | 962,642 |
| TOTAL | $5,454,859 | $5,025,714 | $5,035,243 | $5,153,793 | $5,486,113 |
| Total Assets | $13,659,690 | $12,702,570 | $12,050,590 | $11,742,480 | $13,740,150 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 159,662 | 93,933 | 109,075 | 90,050 | 128,376 |
| Accounts payable and accrued liabilities | 733,138 | 573,290 | 582,722 | 608,522 | 882,585 |
| Other current liabilities | 4,627,085 | 4,582,588 | 4,548,406 | 5,176,988 | 4,501,718 |
| TOTAL | $6,081,902 | $5,743,779 | $5,719,482 | $6,365,532 | $6,006,749 |
| Non-Current Liabilities | |||||
| aiOther Non-Current Liabilities | 587,909 | 529,603 | 532,038 | 503,009 | 547,738 |
| TOTAL | $588,802 | $531,243 | $534,854 | $509,376 | $548,986 |
| Total Liabilities | $6,670,704 | $6,275,022 | $6,254,336 | $6,874,908 | $6,555,734 |
| Shareholders' Equity | |||||
| Common Shares | 77,376 | 77,532 | 77,064 | 80,348 | 94,499 |
| Retained earnings | 6,966,221 | 6,381,033 | 5,832,115 | 5,274,164 | 7,359,689 |
| Other shareholders' equity | -53,610 | -30,013 | -111,929 | -484,939 | -267,768 |
| TOTAL | $6,988,987 | $6,427,552 | $5,796,250 | $4,867,573 | $7,184,420 |
| Total Liabilities And Equity | $13,659,691 | $12,702,574 | $12,050,586 | $11,742,481 | $13,740,154 |